Ildong Pharmaceutical "Aiming for a New Leap Forward Through Innovation This Year"
[Asia Economy Reporter Cho Hyun-ui] Ildong Pharmaceutical Group has set this year's management indicator as 'a leap forward through innovative performance creation.'
On the 2nd, Ildong Pharmaceutical Group announced this and established three management policies: ▲ Quality First ▲ Prompt Execution ▲ Profitability Improvement.
Through performance-centered efficient management, the group plans not only to achieve its goals but also to spare no effort in securing mid- to long-term growth engines such as new drug development. In particular, it intends to accelerate ongoing new drug pipeline research and development (R&D).
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Lee Jung-chi, Chairman of Ildong Holdings, said, "We have the resilience to exert more strength in difficult times," adding, "The current Ildong is much stronger than the past Ildong, so please work with confidence."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
